Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Acta Crystallographica. Section F, Structural Biology Communications|March 3, 2018
A novel inhibitor stabilizes the inactive conformation of MAPK-interacting kinase 1Yumi Matsui, Isao Yasumatsu, Ken Ichi Yoshida, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Structure-Activity Relationship Studies of 3- or 4-Pyridine Derivatives of DS-6930Tsuyoshi Shinozuka, Tomoharu Tsukada, Kunihiko Fujii, et al.
Archives of Oral Biology|September 21, 2016
Differences between the activity of the masticatory muscles of adults with cerebral palsy and healthy individuals while at rest and in functionMiriam Yumi Matsui, Lilian Chrystiane Giannasi, Sandra Regina Freitas Batista, et al.
Bioorganic & Medicinal Chemistry Letters|August 5, 2015
Discovery and structure-guided optimization of tert-butyl 6-(phenoxymethyl)-3-(trifluoromethyl)benzoates as liver X receptor agonistsYumi Matsui, Takahiro Yamaguchi, Takanori Yamazaki, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Structure-Based Design and Synthesis of an Isozyme-Selective MTHFD2 Inhibitor with a Tricyclic Coumarin ScaffoldJunya Kawai, Masahiro Ota, Hitoshi Ohki, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2012
Design and discovery of new (3S,5R)-5-[4-(2-chlorophenyl)-2,2-dimethyl-5-oxopiperazin-1-yl]piperidine-3-carboxamides as potent renin inhibitorsYutaka Mori, Yasuyuki Ogawa, Akiyoshi Mochizuki, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of DS-8108b, a Novel Orally Bioavailable Renin InhibitorYuji Nakamura, Teppei Fujimoto, Yasuyuki Ogawa, et al.
Biological & Pharmaceutical Bulletin|July 2, 2011
Pharmacology and in vitro profiling of a novel peroxisome proliferator-activated receptor γ ligand, Cerco-AKenji Wakabayashi, Shinko Hayashi, Yumi Matsui, et al.
Archives of Oral Biology|September 8, 2014
Test-retest reliability of electromyographic variables of masseter and temporal muscles in patients with cerebral palsyLilian Chrystiane Giannasi, Miriam Yumi Matsui, Fabiano Politti, et al.
Molecular Cancer Therapeutics|January 9, 2023
Discovery of a Novel ATP-Competitive MEK Inhibitor DS03090629 that Overcomes Resistance Conferred by BRAF Overexpression in BRAF-Mutated MelanomaKohei Takano, Yoichi Munehira, Mana Hatanaka, et al.
Pageof 3